Cellulite Treatment Market Research Report—Forecast to 2027

Abstract
Cellulite Treatment Market Research Report Forecast to 2027

Market Forecast
As per the MRFR analysis, the global cellulite treatment market is projected to register a notable market growth at a CAGR of 8.97% during the forecast period to record a largest market value of USD 1,086.44 million by the end of. Cellulite is the dimpled skin disorder that causes uneven, dimpled tissue on the thighs, rear end hips, and midsection. There are different treatments are accessible to work on the presence of cellulite. The global market expansion is attributed to the rising interest for stylish and corrective techniques, Expanding umber of corpulent cases across the globe.

The global cellulite treatment market is anticipated to witness a significant market expansion owing to the rising number of hefty cases across the globe, rising interest for tasteful and corrective systems and developing clinical the travel industry. Developing reception of restorative techniques in arising economies is supposed to help the development of cellulite treatment market. Nonetheless, concerns relating to swelling and enlarging post treatment and lack of prepared and experienced dermatologist/plastic specialist is expected to hamper the market development.

Segment Overview
Global Cellulite Treatment Market is classified into treatment procedures, cellulite type, and region. In terms of treatment procedures, the global market is categorized into Non-Invasive, Minimally Invasive, and Topical.
The Cellulite type segment divides the market into Soft Cellulite, Hard Cellulite, and Edematous Cellulite.

Regional Analysis
Geographically, the global cellulite treatment market is studied across five major segments namely North America, Europe, Asia-Pacific, and Rest of the world.
North America is estimated to dominate the market owing to the largest market of US; it holds the most outrageous regional market of around 92.80% of the all-out market, enlisting USD 218.47 million market size in 2020. The locale is supposed to hold the largest market share of the overall business in the base year inferable from the presence of many major market players across the district, an expanding number of thing dispatches in the area, and expanding care about various sorts of cellulite treatment among the young populace. The business players have placed enormous capital in developing new advancements, gadgets, treatments, and injectables.

Asia Pacific is supposed to select the speediest CAGR of 10.98% during the figure time period from 2021 to 2027. This is because of expanding revenue in innovative headway, rising speculation of market players in R&D activities to encourage new treatment gadgets, creating revenue for spas and health centers, expanding care programs through internet-based entertainment channels across the area, and long stationary working hours. The ascent in stationary working hours is the significant justification for cellulite collection among used ladies in Asia Pacific. Such a way of life is accelerating the treatment of cellulite evacuation among young female specialists. Mesotherapy is the most famous cellulite treatment strategy in Japan.

Key Players
The prominent players in the global cellulite treatment market are Hologic, Inc. (US), Merz Pharma GmbH & Co. KGaA (Germany), Inceler Medikal Co. Ltd (Turkey), Candela Medical (US), Cutera, Inc (US), Zimmer Aesthetics (Germany), Nubway Co.Ltd. (China), Cymedics (Germany), Cynosure, Inc (US), and Beijing Sincoheren S & T Development Co., Ltd (China).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Content
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE
4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
4.2.3 GROWING MEDICAL TOURISM INDUSTRY
4.3 RESTRAINTS
4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING
4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON
4.4 OPPORTUNITY
4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE
5.3.3 IMPACT ON DEMAND AND SUPPLY
5.3.4 IMPACT ON REGIONS
6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE
6.1 OVERVIEW
6.2 NON-INVASIVE
6.3 TOPICAL
6.4 MINIMALLY INVASIVE
6.5 OTHERS
7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE
7.1 OVERVIEW
7.2 SOFT CELLULITE
7.3 HARD CELLULITE
7.4 EDEMATOUS CELLULITE
8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 SPECIALISED DERMATOLOGY CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 OTHERS
9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET
10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11 COMPANY PROFILES
11.1 HOLOGIC, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NUBWAY CO.LTD.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 MERZ PHARMA GMBH & CO. KGAA
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 ZIMMER AESTHETICS
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 CYMEDICS
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 CYNOSURE, LLC
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 INCELER MEDIKAL CO. LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 CANDELA MEDICAL
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 CUTERA, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
 
 


LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL: CELLULITE TREATMENT MARKET, FOR NON-INVASIVE, BY REGION, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL: CELLULITE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL: CELLULITE TREATMENT MARKET, FOR MINIMALLY INVASIVE, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 GLOBAL: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 9 GLOBAL: CELLULITE TREATMENT MARKET, FOR SOFT CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 10 GLOBAL: CELLULITE TREATMENT MARKET, FOR HARD CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 11 GLOBAL: CELLULITE TREATMENT MARKET, FOR EDEMATOUS CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: CELLULITE TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)
TABLE 14 GLOBAL: CELLULITE TREATMENT MARKET, FOR SPECIALISED DERMATOLOGY CLINICS, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: CELLULITE TREATMENT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 19 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 20 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 21 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 22 US: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 23 US: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 24 US: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 25 CANADA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 26 CANADA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 27 CANADA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 28 EUROPE: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 29 EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 30 EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 31 EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 32 GERMANY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 33 GERMANY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 34 GERMANY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 35 UK: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 36 UK: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 37 UK: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 38 FRANCE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 39 FRANCE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 40 FRANCE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 41 ITALY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 42 ITALY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 43 ITALY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 44 SPAIN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 45 SPAIN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 46 SPAIN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 47 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 48 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 49 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 50 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 52 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 54 CHINA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 55 CHINA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 56 CHINA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 57 JAPAN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 58 JAPAN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 59 JAPAN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 60 INDIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 61 INDIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 62 INDIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 63 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 64 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 65 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 66 AUSTRALIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 67 AUSTRALIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 68 AUSTRALIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 69 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 70 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 71 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 72 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 73 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 74 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 75 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 76 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 77 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 78 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 79 AFRICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 80 AFRICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 81 AFRICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 82 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 83 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 84 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 85 MAJOR PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET
TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL CELLULITE TREATMENT MARKET
TABLE 87 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 88 HOLOGIC, INC: PRODUCTS/SERVICES OFFERED
TABLE 89 NUBWAY CO.LTD.: PRODUCTS/SERVICES OFFERED
TABLE 90 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED
TABLE 91 ZIMMER AESTHETICS: PRODUCTS/SERVICES OFFERED
TABLE 92 CYMEDICS: PRODUCTS/SERVICES OFFERED
TABLE 93 CYNOSURE, LLC: PRODUCTS/SERVICES OFFERED
TABLE 94 INCELER MEDIKAL CO. LTD.: PRODUCTS/SERVICES OFFERED
TABLE 95 CANDELA MEDICAL: PRODUCTS/SERVICES OFFERED
TABLE 96 CUTERA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 97 CUTERA, INC.: KEY DEVELOPMENTS
TABLE 98 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.: PRODUCTS/SERVICES OFFERED